Metformin, Explained
Metformin is one of the most widely used medications in type 2 diabetes, and it is often the first one a clinician considers. This is a plain-language explainer of what it is, how it broadly works, and the common considerations that come up — written to inform, not to advise. Whether metformin is right for any individual, and how it is used and monitored, are decisions made with a qualified clinician.
This article sits within our type 2 diabetes guide and expands on one class from our medications overview.
What metformin is
Metformin belongs to a class of medicines called biguanides. It has been in use for decades and is taken by mouth. In discussions of type 2 diabetes, it is frequently described as a first-line medication — meaning it is commonly among the first options considered, usually alongside changes to diet, activity, and other habits. That said, "first-line" is a general pattern, not a universal rule; what is appropriate depends on the individual.
How it works
Metformin acts in two main ways. First, it lowers the amount of glucose the liver produces and releases into the bloodstream — the liver normally makes glucose between meals, and in type 2 diabetes it can make too much. Second, it improves insulin sensitivity, helping the body's muscles and other tissues respond more effectively to the insulin already present. Notably, it does not work by pushing the pancreas to pump out more insulin.
Why it usually doesn't cause low blood sugar
Because metformin does not force the body to release extra insulin, taken on its own it generally does not cause hypoglycemia (low blood sugar). This is one of the features that makes it attractive as an early option. The picture can change when metformin is combined with medications that do increase insulin — such as insulin itself or sulfonylureas — in which case the risk of low blood sugar can rise. That is one of many reasons combinations are managed carefully by a clinician.
Common considerations and side effects
Like any medication, metformin has considerations worth understanding in general terms:
- Gastrointestinal effects. The most common are digestive — such as nausea, an upset stomach, or diarrhea. These often ease over time, and clinicians have strategies to reduce them.
- Vitamin B12. With long-term use, some people can have lower vitamin B12 levels, so clinicians may monitor this periodically.
- Kidney function and lactic acidosis. A very rare but serious complication called lactic acidosis is linked to reduced kidney function. This is why kidney function is typically checked before and during use — a connection explored in our guide to diabetes and kidney disease.
These points are educational and general. They are not a checklist for self-managing a prescription, and they do not cover every person's situation.
How it fits into a wider plan
Metformin is often a starting point rather than the whole story. Over time, a clinician may combine it with other classes described in our medications overview — such as GLP-1 receptor agonists — depending on other health conditions, goals, and how glucose responds. Prescribing, dose decisions, and monitoring are all handled by the clinician. Endobits is clinical decision-support software used under clinician oversight; it helps organise and interpret glucose data to support those conversations, and it does not prescribe medication.
Seeing how your glucose responds
See how glucose data can be organised and put in context over time — a helpful starting point for a conversation with your care team.
Check your glucoseSources
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) — Insulin, Medicines, & Other Diabetes Treatments. American Diabetes Association — Standards of Care in Diabetes (Pharmacologic Approaches to Glycemic Treatment). U.S. Food and Drug Administration — Drugs (prescribing information and safety).
Related: The type 2 diabetes guide · Medications overview · GLP-1 receptor agonists · Glossary